Tempus AI
Prezzo: 47.82Società e modello di business
Tempus AI operates in the healthcare sector, focusing on data-driven solutions for precision medicine. Its core products include genomic sequencing, clinical data analysis, and AI-driven insights aimed at improving patient outcomes. Major business segments encompass oncology, cardiology, and rare diseases, with primary revenue sources stemming from partnerships with healthcare providers and pharmaceutical companies.
Profilo di investimento
The investment profile of Tempus AI is more aligned with growth investors, given its focus on innovative healthcare solutions and potential market expansion. However, the high risk associated with its current performance metrics suggests caution. The stock may appeal to those with a medium to long-term horizon, seeking exposure to advancements in healthcare technology.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- -1.71 Rischio
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -5.2% ↓
- Sorpresa EPS
- 38.1% meglio del previsto
- Volatilità 20g
- 4.8% stabile
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-08 15:26 | — | Vendi | scenario_deterioration |
| 2026-05-05 02:40 | Vendi | Mantieni | Компания показывает положительную динамику выручки и краткосрочный рост, однако отрицательный EPS и значительное падение за 120 дней указывают на высокие риски. |
| 2026-04-27 02:41 | Mantieni | Vendi | Компания демонстрирует значительное снижение цены за последние 120 дней и отрицательный EPS, что указывает на высокие риски. Несмотря на положительные показатели роста выручки, общая динамика акций вызывает опасения. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-11 10:19 | H.C. Wainwright | Target abbassato | 95 → 64 | 49.86 |
| 2026-05-10 14:07 | BTIG | Target abbassato | 90 → 80 | 49.86 |
| 2026-03-10 11:21 | H.C. Wainwright | Target alzato | — → 95 | 52.0271 |
Ancora nulla